Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients

To investigate the associated risk factors of rectovaginal fistula

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Locally Advanced Cervical Cancer

Age range

54 year–74 year

Sex eligibility

Female

Study type

Observational

Primary location

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

About this study

To investigate the associated risk factors of rectovaginal fistula in cervical caner patients after radiotherapy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Rectovaginal fistula Cervical cancer

Exclusion criteria

Nil

Treatment and study plan

Primary outcomes

Rate of associated comorbidity or intervention

Time frame: 12 months

Rate of associated comorbidity or intervention in patients with rectovaginalfistula

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Sep 28, 2021
Registry last updated: Sep 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed